# Cencora Ventures

> Cencora Ventures is a VC fund in Philadelphia backing Health Care and Biopharma. See 5 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Philadelphia, United States
- Total investments: 5
- Last investment: Mar 2026
- Lead investor: 60%
- Last updated: Aug 2026
- X (Twitter): https://twitter.com/CencoraGlobal
- Website: https://cencoraventures.cencora.com

Cencora Ventures is a VC fund in Philadelphia focused on Health Care and Biopharma. Cencora Ventures, formerly known as AB Health Ventures, is a $150 million corporate venture fund that was originally started by AmerisourceBergen, prior to becoming Cencora in August 2023. The fund both invests and provides commercial support to emerging healthcare startup companies.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 60% |
| Biopharma | 1 | 20% |
| Therapeutics | 1 | 20% |
| Pharmaceutical | 1 | 20% |
| Enterprise Software | 1 | 20% |

7 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 3 | 60% |
| Series B | 2 | 40% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| NexCure | NexCure offers clinically intense therapies in outpatient, community settings, revolutionizing the delivery, monitoring, and scaling of CAR-T and other cutting-edge treatments. | $19M | Series A | Mar 05, 2026 |  |
| RISA Labs | We exist for humanity 2Win. Pioneering BOSS [Business (Operating System) as Service]. Trusted by Top Oncologists, we serve mission critical enterprises. Transforming key operations with AI-driven discipline. Headquartered in Silicon Valley, RISA has offices across the globe. | $11.1M | Series A | Jan 13, 2026 |  |
| Lumata Health | Lumata Health is a technology-driven healthcare startup focused on preventing blindness from chronic eye conditions, managing thousands of people at risk of vision loss across the United States. Founded in 2017 by an ophthalmologist and retina specialist in practice for over 30 years, Stephen R. Fransen, MD, and supported by more than 30 industryluminaries and influencers on its Advisory Board, Lumata Health aims to stop preventable blindness with a human-led, intelligent care coordination and management platform that’s almost always free to the patient. The company partners with physicians, payers and health systems to offer turnkey care management services provided by eye care experts who are supported by cutting edge technology and data science. Lumata Health’s programs improve clinical outcomes, patient satisfaction, and clinic staff efficiency by providing between-visit patient assistance and care coordination for patients with chronic eye diseases such as diabetic retinopathy, macular degeneration, glaucoma, and dry eye. | $23M | Series B | Mar 05, 2025 |  |
| Atropos Health | Atropos Health rapidly provides personalized real-world evidence for any clinical decision | $33M | Series B | May 23, 2024 |  |
| Acclinate | Acclinate is a venture-backed, high-growth company that leverages sustained engagement and AI-driven insights to empower communities to take actions for better health. | $7M | Series A | May 07, 2024 |  |

5 of 5 investments shown.

## Co-investors
- [McKesson Ventures](https://shizune.co/investors/profile/mckesson-ventures) — VC Fund, 2 deals together
- [Oncology Ventures](https://shizune.co/investors/profile/oncology-ventures) — VC Fund, 2 deals together
- [Breyer Capital](https://shizune.co/investors/profile/breyer-capital) — VC Fund, 1 deal together
- [Cortado Ventures](https://shizune.co/investors/profile/cortado-ventures) — VC Fund, 1 deal together
- [Emerson Collective](https://shizune.co/investors/profile/emerson-collective) — VC Fund, 1 deal together
- [LabCorp](https://shizune.co/investors/profile/laboratory-corporation-of-america) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Cencora Ventures invest in?

Cencora Ventures invests primarily in Health Care, Biopharma and Therapeutics startups, most often at Series A and Series B stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Cencora Ventures last invest?

The most recent investment recorded for Cencora Ventures closed in Mar 2026. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co